Andere talen Vivoryon Therapeutics N.V.

Aandelen

VVY

NL00150002Q7

Real Time Euronext Amsterdam Andere beurzen 12:44:46 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,92 ^EUR	+27,78%		+120,40%	-88,59%

09:18	Vivoryon stopt eerder met studie naar middel tegen Alzheimer	AM
16/04	Vivoryon publiceert cijfers 2023 eind april	AM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Vivoryon Therapeutics N : Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates	10:06
Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates	07:02
Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates	07:01
Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024	16/04
Vivoryon Therapeutics N : Vivoryon Therapeutics N.V. Announces Changes to Board Composition	15/03
Vivoryon Therapeutics N.V. Announces Changes to Board Composition	15/03
Vivoryon Therapeutics N.V. Announces Changes to Board Composition	15/03
Vivoryon Therapeutics N.V Announces Resignation of Board of Directors	15/03
Vivoryon Therapeutics N : Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease	04/03
Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease	04/03
Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease	04/03
Vivoryon Therapeutics N.V. Provides Update on Viviad Phase 2B Study of Varoglutamstat in Early Alzheimer?S Disease	04/03
SMALL & MIDCAPS : tour d'Europe des recommandations d'analystes	05/02
Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024	08/01
Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024	08/01
Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress	06/12
Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress	06/12
Vivoryon Therapeutics N.V. Announces Executive Changes	06/12
Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023	28/11
Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference	07/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Vivoryon Therapeutics N.V.

Aandelen

VVY

NL00150002Q7

Andere talen

Filters